KATHRYN POOLE: Open Payments
NPI 1689154452 · PAOLI, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 49 payments from 14 companies in 2025. Trend: 2023 $837 · 2024 $818 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $269 |
| ABBVIE INC. | 11 | $159 |
| Lilly USA, LLC | 10 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Novo Nordisk Inc | 3 | $48 |
| Merck Sharp & Dohme LLC | 3 | $45 |
| Exact Sciences Corporation | 2 | $41 |
| Biogen, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
Products named: AIRSUPRA, MOUNJARO, UBRELVY, CAPLYTA, BREZTRI, QULIPTA, The Cologuard Plus Collection Kit, ZURZUVAE.
Industry payments across IN — which companies pay providers there.
